Cerca
Menu
Foto del docente

Alessandro De Vita

Professore a contratto

Dipartimento di Farmacia e Biotecnologie

Pubblicazioni

  1. Mercatali L, Vanni S, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Fausti V, Riva N, Genovese D, Lucarelli E, Focarete ML, Ibrahim T, Calabrò L, De Vita A. The emerging role of cancer nanotechnology in the panorama of sarcoma. Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. PMID: 36324885; PMCID: PMC9618700.
  2. Ranallo N, Iamurri AP, Foca F, Liverani C, De Vita A, Mercatali L, Calabrese C, Spadazzi C, Fabbri C, Cavaliere D, Galassi R, Severi S, Sansovini M, Tartaglia A, Pieri F, Crudi L, Bianchini D, Barone D, Martinelli G, Frassineti GL, Ibrahim T, Calabrò L, Berardi R, Bongiovanni A. Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis. Cancers (Basel). 2022 Jun 30;14(13):3231. doi: 10.3390/cancers14133231. PMID: 35805003; PMCID: PMC9264955.
  3. Plousiou M, De Vita A, Miserocchi G, Bandini E, Vannini I, Melloni M, Masalu N, Fabbri F, Serra P. Growth Inhibition of Retinoblastoma Cell Line by Exosome-Mediated Transfer of miR-142-3p. Cancer Manag Res. 2022 Jun 29;14:2119-2131. doi: 10.2147/CMAR.S351979. PMID: 35791342; PMCID: PMC9250773.
  4. Vanni S, De Vita A, Gurrieri L, Fausti V, Miserocchi G, Spadazzi C, Liverani C, Cocchi C, Calabrese C, Bongiovanni A, Riva N, Mercatali L, Pieri F, Casadei R, Lucarelli E, Ibrahim T. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives. Ther Adv Med Oncol. 2022 Jun 28;14:17588359221093973. doi: 10.1177/17588359221093973. PMID: 35782752; PMCID: PMC9244941.
  5. Miserocchi G, Spadazzi C, Calpona S, De Rosa F, Usai A, De Vita A, Liverani C, Cocchi C, Vanni S, Calabrese C, Bassi M, De Luca G, Meccariello G, Ibrahim T, Schiavone M, Mercatali L. Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches. J Pers Med. 2022 May 24;12(6):854. doi: 10.3390/jpm12060854. PMID: 35743639; PMCID: PMC9224778.
  6. De Vita A, Donati DM, Mercatali L, Ibrahim T. New Ground-Breaking Strategies in Bone Regeneration-In Memory of Nerio Ceroni. Biomedicines. 2022 Apr 6;10(4):855. doi: 10.3390/biomedicines10040855. PMID: 35453605; PMCID: PMC9027141.
  7. Liguori A, De Vita A, Rossi G, Dolci LS, Panzavolta S, Gualandi C, Mercatali L, Ibrahim T, Focarete ML. A Modular Composite Device of Poly(Ethylene Oxide)/Poly(Butylene Terephthalate) (PEOT/PBT) Nanofibers and Gelatin as a Dual Drug Delivery System for Local Therapy of Soft Tissue Tumors. Int J Mol Sci. 2022 Mar 17;23(6):3239. doi: 10.3390/ijms23063239. PMID: 35328661; PMCID: PMC8948985.
  8. De Vita A, Vanni S, Miserocchi G, Fausti V, Pieri F, Spadazzi C, Cocchi C, Liverani C, Calabrese C, Casadei R, Recine F, Gurrieri L, Bongiovanni A, Ibrahim T, Mercatali L. A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences. Biomedicines. 2022 Feb 3;10(2):372. doi: 10.3390/biomedicines10020372. PMID: 35203581; PMCID: PMC8962296.
  9. Recine F, De Vita A, Fausti V, Pieri F, Bongiovanni A, Franchini E, Casadei R, Falasconi MC, Oboldi D, Matteucci F, Pallotti MC, Mercatali L, Riva N, Gurrieri L, Vanni S, Liverani C, Miserocchi G, Spadazzi C, Cocchi C, Ibrahim T. Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy. Front Oncol. 2022 Jan 7;11:740676. doi: 10.3389/fonc.2021.740676. PMID: 35070960; PMCID: PMC8776642.
  10. De Vita A, Vanni S, Fausti V, Cocchi C, Recine F, Miserocchi G, Liverani C, Spadazzi C, Bassi M, Gessaroli M, Campobassi A, De Luca G, Pieri F, Farnedi A, Franchini E, Ferrari A, Domizio C, Cavagna E, Gurrieri L, Bongiovanni A, Riva N, Calpona S, Di Menna G, Debonis SA, Ibrahim T, Mercatali L. Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas. Int J Mol Sci. 2021 Oct 26;22(21):11564. doi: 10.3390/ijms222111564. PMID: 34768995; PMCID: PMC8584142.
  11. De Vita A, Ferrari A, Miserocchi G, Vanni S, Domizio C, Fonzi E, Fausti V, Recine F, Bassi M, Campobassi A, Liverani C, Spadazzi C, Cocchi C, De Luca G, Pieri F, Gurrieri L, Di Menna G, Calpona S, Bongiovanni A, Martinelli G, Ibrahim T, Mercatali L. Identification of a novel RAB3IP-HMGA2 fusion transcript in an adult head and neck rhabdomyosarcoma. Oral Dis. 2022 Oct;28(7):2052-2054. doi: 10.1111/odi.14036. Epub 2021 Oct 10. PMID: 34592033.
  12. Bongiovanni A, Liverani C, Foca F, Fausti V, Di Menna G, Mercatali L, De Vita A, Riva N, Calpona S, Miserocchi G, Spadazzi C, Cocchi C, Ibrahim T. Temozolomide Alone or Combined with Capecitabine for the Treatment of Metastatic Neuroendocrine Neoplasia: A "Real-World" Data Analysis. Neuroendocrinology. 2021;111(9):895-906. doi: 10.1159/000513218. Epub 2020 Nov 20. PMID: 33221806.
  13. Tazzari M, Bergamaschi L, De Vita A, Collini P, Barisella M, Bertolotti A, Ibrahim T, Pasquali S, Castelli C, Vallacchi V. Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention. Int J Mol Sci. 2021 Jul 13;22(14):7518. doi: 10.3390/ijms22147518. PMID: 34299136; PMCID: PMC8303572.
  14. Liverani C, De Vita A, Spadazzi C, Miserocchi G, Cocchi C, Bongiovanni A, De Lucia A, La Manna F, Fabbri F, Tebaldi M, Amadori D, Tasciotti E, Martinelli G, Mercatali L, Ibrahim T. Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture. Mol Oncol. 2022 Feb;16(4):921-939. doi: 10.1002/1878-0261.13037. Epub 2021 Jul 10. PMID: 34109737; PMCID: PMC8847989.
  15. Miserocchi G, Cocchi C, De Vita A, Liverani C, Spadazzi C, Calpona S, Di Menna G, Bassi M, Meccariello G, De Luca G, Campobassi A, Maddalena Tumedei M, Bongiovanni A, Fausti V, Cotelli F, Ibrahim T, Mercatali L. Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas. Cancer Biol Med. 2021 Mar 27;18(2):502–16. doi: 10.20892/j.issn.2095-3941.2020.0482. Epub ahead of print. PMID: 33772505; PMCID: PMC8185858.
  16. De Vita A, Recine F, Miserocchi G, Pieri F, Spadazzi C, Cocchi C, Vanni S, Liverani C, Farnedi A, Fabbri F, Fausti V, Casadei R, Brandolini F, Ercolani G, Cavaliere D, Bongiovanni A, Riva N, Gurrieri L, Di Menna G, Calpona S, Debonis SA, Mercatali L, Ibrahim T. The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models. J Exp Clin Cancer Res. 2021 May 11;40(1):165. doi: 10.1186/s13046-021-01963-1. PMID: 33975637; PMCID: PMC8111914.
  17. Debonis SA, Bongiovanni A, Pieri F, Fausti V, De Vita A, Riva N, Gurrieri L, Vanni S, Diano D, Mercatali L, Ibrahim T. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations. Medicine (Baltimore). 2021 May 21;100(20):e25972. doi: 10.1097/MD.0000000000025972. PMID: 34011083; PMCID: PMC8137108.
  18. De Vita A, Liverani C, Molinaro R, Martinez JO, Hartman KA, Spadazzi C, Miserocchi G, Taraballi F, Evangelopoulos M, Pieri F, Bongiovanni A, Mercatali L, Tasciotti E, Ibrahim T. Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer. Sci Rep. 2021 Mar 3;11(1):5107. doi: 10.1038/s41598-021-84492-3. PMID: 33658580; PMCID: PMC7930284.
  19. Liverani C, Bongiovanni A, Mercatali L, Pieri F, Spadazzi C, Miserocchi G, Di Menna G, Foca F, Ravaioli S, De Vita A, Cocchi C, Rossi G, Recine F, Ibrahim T. Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Pathol. 2021 Jun;32(2):309-317. doi: 10.1007/s12022-020-09657-8. Epub 2021 Jan 6. PMID: 33409812.
  20. Spadazzi C, Mercatali L, Esposito M, Wei Y, Liverani C, De Vita A, Miserocchi G, Carretta E, Zanoni M, Cocchi C, Bongiovanni A, Recine F, Kang Y, Ibrahim T. Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis. Bone. 2021 Mar;144:115775. doi: 10.1016/j.bone.2020.115775. Epub 2020 Nov 27. PMID: 33249323.
  21. De Vita A, Bongiovanni A, Blay JY, Ibrahim T. Editorial: New Insights Into the Landscape of Rare Tumors: Translational and Clinical Research Perspective. Front Oncol. 2020 Oct 29;10:593785. doi: 10.3389/fonc.2020.593785. PMID: 33194758; PMCID: PMC7659953.
  22. Parodi A, Evangelopoulos M, Arrighetti N, Cevenini A, Livingston M, Khaled SZ, Brown BS, Yazdi IK, Paradiso F, Campa-Carranza JN, De Vita A, Taraballi F, Tasciotti E. Endosomal Escape of Polymer-Coated Silica Nanoparticles in Endothelial Cells. Small. 2020 Sep;16(36):e1907693. doi: 10.1002/smll.201907693. Epub 2020 Jul 9. PMID: 32643290.
  23. Racanelli D, Brenca M, Baldazzi D, Goeman F, Casini B, De Angelis B, Guercio M, Milano GM, Tamborini E, Busico A, Dagrada G, Garofalo C, Caruso C, Brunello A, Pignochino Y, Berrino E, Grignani G, Scotlandi K, Parra A, Hattinger CM, Ibrahim T, Mercatali L, De Vita A, Carriero MV, Pallocca M, Loria R, Covello R, Sbaraglia M, Dei Tos AP, Falcioni R, Maestro R. Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group. Front Oncol. 2020 Apr 15;10:489. doi: 10.3389/fonc.2020.00489. Erratum in: Front Oncol. 2020 Jun 23;10:944. PMID: 32351889; PMCID: PMC7175964.
  24. Bongiovanni A, Liverani C, Recine F, Fausti V, Mercatali L, Vagheggini A, Spadazzi C, Miserocchi G, Cocchi C, Di Menna G, De Vita A, Severi S, Nicolini S, Ibrahim T. Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis. Front Oncol. 2020 Apr 7;10:414. doi: 10.3389/fonc.2020.00414. PMID: 32318336; PMCID: PMC7154093.
  25. Molinaro R, Martinez JO, Zinger A, De Vita A, Storci G, Arrighetti N, De Rosa E, Hartman KA, Basu N, Taghipour N, Corbo C, Tasciotti E. Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma. Biomater Sci. 2020 Jan 1;8(1):333-341. doi: 10.1039/c9bm01766f. Epub 2019 Nov 12. PMID: 31714542.
  26. Recine F, Bongiovanni A, Foca F, Mercatali L, Fausti V, Calpona S, Riva N, De Vita A, Liverani C, Spadazzi C, Miserocchi G, Di Menna G, Gurrieri L, Cocchi C, Debonis SA, Vespignani R, Ibrahim T. BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center "Real-Life" Experience (BOHEME Study). J Clin Med. 2019 Nov 6;8(11):1894. doi: 10.3390/jcm8111894. PMID: 31698876; PMCID: PMC6912302.
  27. Liverani C, De Vita A, Minardi S, Kang Y, Mercatali L, Amadori D, Bongiovanni A, La Manna F, Ibrahim T, Tasciotti E. A biomimetic 3D model of hypoxia-driven cancer progression. Sci Rep. 2019 Aug 22;9(1):12263. doi: 10.1038/s41598-019-48701-4. PMID: 31439905; PMCID: PMC6706452.
  28. Bongiovanni A, Recine F, Fausti V, Rossi B, Mercatali L, Liverani C, De Vita A, Gurrieri L, De Bonis S, Miserocchi G, Spadazzi C, Calpona S, Riva N, Cocchi C, Ibrahim T. Clinical role of filgrastim in the management of patients at risk of prolonged severe neutropenia: An evidence-based review. Int J Clin Pract. 2019 Nov;73(11):e13404. doi: 10.1111/ijcp.13404. Epub 2019 Sep 13. PMID: 31408256.
  29. Spadazzi C, Recine F, Mercatali L, Miserocchi G, Liverani C, De Vita A, Bongiovanni A, Fausti V, Ibrahim T. mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model. J Bone Oncol. 2019 Feb 27;16:100227. doi: 10.1016/j.jbo.2019.100227. PMID: 30911462; PMCID: PMC6416775.
  30. Liverani C, Bongiovanni A, Mercatali L, Foca F, Pieri F, De Vita A, Spadazzi C, Miserocchi G, Recine F, Riva N, Nicolini S, Severi S, Martinelli G, Ibrahim T. Grading of Neuroendocrine Carcinomas: Correlation of 68Ga-PET/CT Scan with Tissue Biomarkers. Dis Markers. 2018 Dec 2;2018:6878409. doi: 10.1155/2018/6878409. PMID: 30627226; PMCID: PMC6304840.
  31. Bongiovanni A, Recine F, Foca F, Fausti V, Riva N, Fabbri G, Severi S, Liverani C, De Vita A, Spadazzi C, Miserocchi G, Mercatali L, Amadori D, Ibrahim T. Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age. Endocr Connect. 2018 Dec;7(12):1535-1541. doi: 10.1530/EC-18-0478. PMID: 30530877; PMCID: PMC6311458.
  32. Miserocchi G, De Vita A, Mercatali L, Recine F, Liverani C, Spadazzi C, Pieri F, Riva N, Bongiovanni A, Casadei R, Fausti V, Ibrahim T. Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line. Cells. 2018 Oct 25;7(11):186. doi: 10.3390/cells7110186. PMID: 30366467; PMCID: PMC6262427.
  33. Mercatali L, Serra P, Miserocchi G, Spadazzi C, Liverani C, De Vita A, Marisi G, Bongiovanni A, Recine F, Pangan A, Masalu N, Ibrahim T, Amadori D. Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers. J Vis Exp. 2018 Jun 11;(136):57113. doi: 10.3791/57113. PMID: 29939179; PMCID: PMC6101696.
  34. De Vita A, Mercatali L, Miserocchi G, Liverani C, Spadazzi C, Recine F, Bongiovanni A, Pieri F, Cavaliere D, Fausti V, Amadori D, Ibrahim T. Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma. J Vis Exp. 2018 Apr 11;(134):56767. doi: 10.3791/56767. PMID: 29708525; PMCID: PMC5933451.
  35. De Vita A, Recine F, Mercatali L, Miserocchi G, Liverani C, Spadazzi C, Casadei R, Bongiovanni A, Pieri F, Riva N, Amadori D, Ibrahim T. Myxofibrosarcoma primary cultures: molecular and pharmacological profile. Ther Adv Med Oncol. 2017 Dec;9(12):755-767. doi: 10.1177/1758834017737472. Epub 2017 Oct 28. PMID: 29449896; PMCID: PMC5808841.
  36. De Vita A, Recine F, Mercatali L, Miserocchi G, Spadazzi C, Liverani C, Bongiovanni A, Pieri F, Casadei R, Riva N, Fausti V, Amadori D, Ibrahim T. Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents. Int J Mol Sci. 2017 Dec 8;18(12):2662. doi: 10.3390/ijms18122662. PMID: 29292724; PMCID: PMC5751264.
  37. Bongiovanni A, Recine F, Celli M, Marcantognini G, Foca F, Liverani C, Fausti V, De Vita A, Miserocchi G, Mercatali L, Amadori D, Ibrahim T. Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature. Medicine (Baltimore). 2017 Nov;96(46):e8567. doi: 10.1097/MD.0000000000008567. PMID: 29145267; PMCID: PMC5704812.
  38. Recine F, Bongiovanni A, Casadei R, Pieri F, Riva N, De Vita A, Mercatali L, Liverani C, Spadazzi C, Miserocchi G, Fausti V, Amadori D, Ibrahim T. Primary leiomyosarcoma of the bone: a case report and a review of the literature. Medicine (Baltimore). 2017 Nov;96(45):e8545. doi: 10.1097/MD.0000000000008545. PMID: 29137065; PMCID: PMC5690758.
  39. Miserocchi G, Mercatali L, Liverani C, De Vita A, Spadazzi C, Pieri F, Bongiovanni A, Recine F, Amadori D, Ibrahim T. Management and potentialities of primary cancer cultures in preclinical and translational studies. J Transl Med. 2017 Nov 7;15(1):229. doi: 10.1186/s12967-017-1328-z. PMID: 29116016; PMCID: PMC5688825.
  40. Mercatali L, Spadazzi C, Miserocchi G, Liverani C, De Vita A, Bongiovanni A, Recine F, Amadori D, Ibrahim T. Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines. J Vis Exp. 2017 Sep 13;(127):56311. doi: 10.3791/56311. PMID: 28930982; PMCID: PMC5752253.
  41. Mercatali L, La Manna F, Miserocchi G, Liverani C, De Vita A, Spadazzi C, Bongiovanni A, Recine F, Amadori D, Ghetti M, Ibrahim T. Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition. Int J Mol Sci. 2017 Jul 29;18(8):1655. doi: 10.3390/ijms18081655. PMID: 28758931; PMCID: PMC5578045.
  42. Liverani C, Mercatali L, Cristofolini L, Giordano E, Minardi S, Porta GD, De Vita A, Miserocchi G, Spadazzi C, Tasciotti E, Amadori D, Ibrahim T. Investigating the Mechanobiology of Cancer Cell-ECM Interaction Through Collagen-Based 3D Scaffolds. Cell Mol Bioeng. 2017 Mar 6;10(3):223-234. doi: 10.1007/s12195-017-0483-x. PMID: 31719861; PMCID: PMC6816786.
  43. Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T. Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas. Onco Targets Ther. 2017 Feb 23;10:1155-1164. doi: 10.2147/OTT.S127955. PMID: 28260930; PMCID: PMC5328291.
  44. De Vita A, Miserocchi G, Recine F, Mercatali L, Pieri F, Medri L, Bongiovanni A, Cavaliere D, Liverani C, Spadazzi C, Amadori D, Ibrahim T. Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma. Molecules. 2016 Dec 3;21(12):1662. doi: 10.3390/molecules21121662. PMID: 27918490; PMCID: PMC6273088.
  45. Liverani C, La Manna F, Groenewoud A, Mercatali L, Van Der Pluijm G, Pieri F, Cavaliere D, De Vita A, Spadazzi C, Miserocchi G, Bongiovanni A, Recine F, Riva N, Amadori D, Tasciotti E, Snaar-Jagalska E, Ibrahim T. Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. Biol Open. 2017 Feb 15;6(2):133-140. doi: 10.1242/bio.022483. Erratum in: Biol Open. 2017 Feb 15;6(2):309. PMID: 27895047; PMCID: PMC5312106.
  46. Mercatali L, Spadazzi C, Miserocchi G, Liverani C, De Vita A, Bongiovanni A, Recine F, Amadori D, Ibrahim T. The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts. Int J Mol Sci. 2016 Nov 1;17(11):1827. doi: 10.3390/ijms17111827. PMID: 27809291; PMCID: PMC5133828.
  47. De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T. Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas. Onco Targets Ther. 2016 Oct 11;9:6233-6246. doi: 10.2147/OTT.S112580. PMID: 27785071; PMCID: PMC5067014.
  48. Ibrahim T, Ricci M, Scarpi E, Bongiovanni A, Ricci R, Riva N, Liverani C, De Vita A, La Manna F, Oboldi D, Serra P, Foca F, Cecconetto L, Amadori D, Mercatali L. RANKL: A promising circulating marker for bone metastasis response. Oncol Lett. 2016 Oct;12(4):2970-2975. doi: 10.3892/ol.2016.4977. Epub 2016 Aug 8. PMID: 27698885; PMCID: PMC5038445.
  49. Bongiovanni A, Monti M, Foca F, Recine F, Riva N, Di Iorio V, Liverani C, De Vita A, Miserocchi G, Mercatali L, Amadori D, Ibrahim T. Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR). Support Care Cancer. 2017 Jan;25(1):111-117. doi: 10.1007/s00520-016-3390-0. Epub 2016 Aug 27. PMID: 27568305.
  50. Mercatali L, La Manna F, Groenewoud A, Casadei R, Recine F, Miserocchi G, Pieri F, Liverani C, Bongiovanni A, Spadazzi C, De Vita A, van der Pluijm G, Giorgini A, Biagini R, Amadori D, Ibrahim T, Snaar-Jagalska E. Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model. Int J Mol Sci. 2016 Aug 22;17(8):1375. doi: 10.3390/ijms17081375. PMID: 27556456; PMCID: PMC5000770.
  51. Molinaro R, Corbo C, Martinez JO, Taraballi F, Evangelopoulos M, Minardi S, Yazdi IK, Zhao P, De Rosa E, Sherman MB, De Vita A, Toledano Furman NE, Wang X, Parodi A, Tasciotti E. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat Mater. 2016 Sep;15(9):1037-46. doi: 10.1038/nmat4644. Epub 2016 May 23. PMID: 27213956; PMCID: PMC5127392.
  52. Bongiovanni A, Riva N, Ricci M, Mercatali L, Liverani C, La Manna F, De Vita A, Cavaliere D, Pieri F, Oboldi D, Verdecchia GM, Amadori D, Ibrahim T. Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report. BMC Cancer. 2015 Dec 22;15:998. doi: 10.1186/s12885-015-2038-7. PMID: 26695071; PMCID: PMC4689051.
  53. Bongiovanni A, Riva N, Ricci M, Liverani C, La Manna F, De Vita A, Foca F, Mercatali L, Severi S, Amadori D, Ibrahim T. First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma. Onco Targets Ther. 2015 Dec 3;8:3613-9. doi: 10.2147/OTT.S91971. PMID: 26664145; PMCID: PMC4671803.
  54. Bongiovanni A, Riva N, Calpona S, Ricci M, Gunelli E, Liverani C, La Manna F, De Vita A, Monti M, Severi S, Pieri F, Amadori E, Galassi R, Cavaliere D, Zaccaroni A, Tartaglia A, Lunedei V, Gardini A, Mercatali L, Amadori D, Ibrahim T. Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature. Onco Targets Ther. 2014 Oct 20;7:1919-26. doi: 10.2147/OTT.S68573. PMID: 25364262; PMCID: PMC4211616.
  55. Bongiovanni A, Ricci M, Riva N, Calpona S, Oboldi D, Pieri F, Cavaliere D, Mercatali L, Liverani C, La Manna F, De Vita A, Foca F, Gunelli E, Amadori D, Ibrahim T. Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report. Future Oncol. 2014 Dec;10(15):2423-7. doi: 10.2217/fon.14.159. PMID: 25525851.
  56. Liverani C, Mercatali L, Spadazzi C, La Manna F, De Vita A, Riva N, Calpona S, Ricci M, Bongiovanni A, Gunelli E, Zanoni M, Fabbri F, Zoli W, Amadori D, Ibrahim T. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems. Bone. 2014 Sep;66:214-22. doi: 10.1016/j.bone.2014.06.017. Epub 2014 Jun 20. PMID: 24956020.
  57. Ruozi B, Belletti D, Bondioli L, De Vita A, Forni F, Vandelli MA, Tosi G. Neurotrophic factors and neurodegenerative diseases: a delivery issue. Int Rev Neurobiol. 2012;102:207-47. doi: 10.1016/B978-0-12-386986-9.00009-0. PMID: 22748832.
  58. Tosi G, Bondioli L, Ruozi B, Badiali L, Severini GM, Biffi S, De Vita A, Bortot B, Dolcetta D, Forni F, Vandelli MA. NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. J Neural Transm (Vienna). 2011 Jan;118(1):145-53. doi: 10.1007/s00702-010-0497-1. Epub 2010 Oct 8. PMID: 20931242.

 

Ultimi avvisi

Tutti gli avvisi RSS